CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer’s disease
Nicolas R. Barthélemy(Washington University in St. Louis), Suzanne E. Schindler(Meharry Medical College), Randall J. Bateman(Washington University in St. Louis), Chihiro Sato(The University of Tokyo), Erik Stomrud(Lund University), Anne M. Fagan(Washington University in St. Louis), Yingxin He(Washington University in St. Louis), Vitaliy Ovod(Washington University in St. Louis), Oskar Hansson(Lund University), Gemma Salvadó(Lund University), Rachel L. Henson(Meharry Medical College), John C. Morris(Mayo Clinic), Shorena Janelidze(Lund University), Kanta Horie(Washington University in St. Louis), Brian A. Gordon(Washington University in St. Louis), Yan Li(Washington University in St. Louis), Tammie L.S. Benzinger(Washington University in St. Louis), Chengjie Xiong(Ludwig-Maximilians-Universität München), Benjamin Saef(Washington University in St. Louis)
Cited by 150
Related Papers
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
|Journal of Neuropathology & Experimental Neurology|2012|2.1k
Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease
|Nature Medicine|2019|948
Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity
|Nature Communications|2017|927